Literature DB >> 10777480

Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions.

J G Williams1, J K Drugan, G S Yi, G J Clark, C J Der, S L Campbell.   

Abstract

Raf-1 is a critical downstream target of Ras and contains two distinct domains that bind Ras. The first Ras-binding site (RBS1) in Raf-1 has been shown to be essential for Ras-mediated translocation of Raf-1 to the plasma membrane, whereas the second site, in the Raf-1 cysteine-rich domain (Raf-CRD), has been implicated in regulating Raf kinase activity. While recognition elements that promote Ras.RBS1 complex formation have been characterized, relatively little is known about Ras/Raf-CRD interactions. In this study, we have characterized interactions important for Ras binding to the Raf-CRD. Reconciling conflicting reports, we found that these interactions are essentially independent of the guanine nucleotide bound state, but instead, are enhanced by post-translational modification of Ras. Specifically, our findings indicate that Ras farnesylation is sufficient for stable association of Ras with the Raf-CRD. Furthermore, we have also identified a Raf-CRD variant that is impaired specifically in its interactions with Ras. NMR data also suggests that residues proximal to this mutation site on the Raf-CRD form contacts with Ras. This Raf-CRD mutant impairs the ability of Ras to activate Raf kinase, thereby providing additional support that Ras interactions with the Raf-CRD are important for Ras-mediated activation of Raf-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777480     DOI: 10.1074/jbc.M000397200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation.

Authors:  Michelle A Booden; Sharon L Campbell; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity.

Authors:  Yvonne Light; Hugh Paterson; Richard Marais
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Structural determinants of Ras-Raf interaction analyzed in live cells.

Authors:  Tzvetanka Bondeva; András Balla; Péter Várnai; Tamas Balla
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

4.  Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Authors:  Pablo Rodriguez-Viciana; Celine Sabatier; Frank McCormick
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 5.  Inhibition of Ras for cancer treatment: the search continues.

Authors:  Antonio T Baines; Dapeng Xu; Channing J Der
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

6.  The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy.

Authors:  Moritz Stolla; Lucia Stefanini; R Claire Roden; Massiel Chavez; Jessica Hirsch; Teshell Greene; Timothy D Ouellette; Sean F Maloney; Scott L Diamond; Mortimer Poncz; Donna S Woulfe; Wolfgang Bergmeier
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

Review 7.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

Review 8.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 9.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02

10.  A CC-SAM, for coiled coil-sterile α motif, domain targets the scaffold KSR-1 to specific sites in the plasma membrane.

Authors:  Dorothy Koveal; Natasha Schuh-Nuhfer; Daniel Ritt; Rebecca Page; Deborah K Morrison; Wolfgang Peti
Journal:  Sci Signal       Date:  2012-12-18       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.